D.E. Shaw & Co
ELOX

D.E. Shaw & Co’s Eloxx Pharmaceuticals, Inc. Common Stock ELOX Stock Holding History

D.E. Shaw & Co’s Portfolio ELOX Stock Details ELOX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q3 		– Sell
-532
Closed -$6K – 5733
2022
Q2 		$6K Hold
532
– – ﹤0.01% 5217
2022
Q1 		$12K Hold
532
– – ﹤0.01% 5404
2021
Q4 		$15K Sell
532
-1,060
-67% -$46.2K ﹤0.01% 5316
2021
Q3 		$104K Buy
+1,592
New +$98.2K ﹤0.01% 4714

Other funds holding ELOX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
MMH
Menora Mivtachim Holdings Ramat Gan, Israel $21.1B AUM 40.03% 1-Year Est. Return
AFG
American Financial Group Cincinnati, Ohio $270M AUM 3.25% 1-Year Est. Return
HIIFS
Harel Insurance Investments & Financial Services Ramat Gan, Israel $14.7B AUM 47% 1-Year Est. Return
SCM
Silverarc Capital Management Boston, Massachusetts $980M AUM 470.8% 1-Year Est. Return
AS
Altshuler Shaham Tel Aviv, Israel $5.54B AUM 44.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
CI
Clal Insurance Tel-Aviv, Israel $16.6B AUM 68.34% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Bridgeway Capital Management Houston, Texas $4.97B AUM 44.96% 1-Year Est. Return

D.E. Shaw & Co's ELOX Position: Q3 2022 in Review

D.E. Shaw & Co sold out of Eloxx Pharmaceuticals, Inc. Common Stock (ELOX) in Q3 2022, closing a stake of 532 shares — an estimated $6K sold.

D.E. Shaw & Co first reported a position in ELOX in Q3 2021 and held it in 4 quarters. The position peaked at $104K in Q3 2021. 30 funds tracked by Wall St. Rank hold ELOX as of Q3 2022.

  • D.E. Shaw & Co reported no remaining Eloxx Pharmaceuticals, Inc. Common Stock position as of Q3 2022 after selling out during the quarter.
  • D.E. Shaw & Co sold 532 Eloxx Pharmaceuticals, Inc. Common Stock shares in Q3 2022, an estimated $6K.
  • D.E. Shaw & Co first reported a position in Eloxx Pharmaceuticals, Inc. Common Stock in Q3 2021 and held it in 4 quarters.
  • D.E. Shaw & Co's Eloxx Pharmaceuticals, Inc. Common Stock position peaked at $104K in Q3 2021.
  • 30 funds tracked by Wall St. Rank held Eloxx Pharmaceuticals, Inc. Common Stock as of Q3 2022.

Based on D.E. Shaw & Co's 13F filing for Q3 2022, filed 14 Nov 2022.